Association of Antiplatelet Therapy, Including Cilostazol, With Improved Survival in Patients With Moyamoya Disease in a Nationwide Study

BACKGROUND: Although antiplatelet agents are frequently prescribed in moyamoya disease in routine clinical practice, there are no large‐scale epidemiologic trials or randomized trial evidence to support their use in patients with moyamoya disease. METHODS AND RESULTS: Using the Korean National Healt...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Heart Assoc
Main Authors: Seo, Woo‐Keun, Kim, Jae‐Young, Choi, Eun‐Hyeok, Kim, Ye‐Sel, Chung, Jong‐Won, Saver, Jeffrey L., Bang, Oh Young, Kim, Gyeong‐Moon
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8174237/
https://ncbi.nlm.nih.gov/pubmed/33615836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.120.017701
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados